Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M BENTLEY

Showing results (181-190 of 198) with videos related to

Pageof 20
Sort By:
Vaccine|April 7, 2007
Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humansS Khan, S Chatfield, R Stratford, et al.
Plos One|November 24, 2016
Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig ModelJoanna L Miller, Simon G Spiro, Stuart D Dowall, et al.
Research Report (Health Effects Institute)|March 31, 2011
Part 2. Association of daily mortality with ambient air pollution, and effect modification by extremely high temperature in Wuhan, ChinaZhengmin Qian, Qingci He, Hung-Mo Lin, et al.
NPJ Vaccines|November 6, 2025
A system to rapidly develop a bunyavirus pseudotyped virus neutralisation assay for pandemic preparednessFederica Marchesin, Emma M Bentley, Francis Mutuku, et al.
Blood|December 12, 2001
The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteinsA Demiroglu, E J Steer, C Heath, et al.
Journal of Virology|July 21, 2021
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 VariantsMathieu Ferrari, Leila Mekkaoui, F Tudor Ilca, et al.
Frontiers in Immunology|March 25, 2022
Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody ThresholdsDiego Cantoni, Martin Mayora-Neto, Angalee Nadesalingam, et al.
The Journal of Surgical Research|July 23, 2013
Palliative and end-of-life care training during the surgical clerkshipKathryn M Tchorz, S Bruce Binder, Mary T White, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2005
Pyrrolo(iso)quinoline derivatives as 5-HT(2C) receptor agonistsDavid R Adams, Jonathan M Bentley, Karen R Benwell, et al.
Transfusion|August 3, 2021
Comparability of six different immunoassays measuring SARS-CoV-2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to predictionAbigail Lamikanra, Dung Nguyen, Peter Simmonds, et al.
Pageof 20

Showing results (181-190 of 198) with videos related to

Sort By:
Pageof 20
Vaccine|April 7, 2007
Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humansS Khan, S Chatfield, R Stratford, et al.
Plos One|November 24, 2016
Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig ModelJoanna L Miller, Simon G Spiro, Stuart D Dowall, et al.
Research Report (Health Effects Institute)|March 31, 2011
Part 2. Association of daily mortality with ambient air pollution, and effect modification by extremely high temperature in Wuhan, ChinaZhengmin Qian, Qingci He, Hung-Mo Lin, et al.
NPJ Vaccines|November 6, 2025
A system to rapidly develop a bunyavirus pseudotyped virus neutralisation assay for pandemic preparednessFederica Marchesin, Emma M Bentley, Francis Mutuku, et al.
Blood|December 12, 2001
The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteinsA Demiroglu, E J Steer, C Heath, et al.
Journal of Virology|July 21, 2021
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 VariantsMathieu Ferrari, Leila Mekkaoui, F Tudor Ilca, et al.
Frontiers in Immunology|March 25, 2022
Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody ThresholdsDiego Cantoni, Martin Mayora-Neto, Angalee Nadesalingam, et al.
The Journal of Surgical Research|July 23, 2013
Palliative and end-of-life care training during the surgical clerkshipKathryn M Tchorz, S Bruce Binder, Mary T White, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2005
Pyrrolo(iso)quinoline derivatives as 5-HT(2C) receptor agonistsDavid R Adams, Jonathan M Bentley, Karen R Benwell, et al.
Transfusion|August 3, 2021
Comparability of six different immunoassays measuring SARS-CoV-2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to predictionAbigail Lamikanra, Dung Nguyen, Peter Simmonds, et al.
Pageof 20